Three more biotechs go public Friday as nothing seems able to slow down the 2020 train
Another day, another three biotechs price their IPOs. Such is 2020 in the biotech industry.
Friday’s winners are Kronos Bio, Shattuck Labs and Spruce Biosciences, all of whom are set to hit Nasdaq. Kronos raised the most of the bunch at $250.8 million. Shattuck also topped the $200 million-mark with a $202 million raise, while Spruce followed up with $90 million.
In terms of pricing, all three priced above their ranges. Kronos did so at $19 per share, Shattuck at $17 per share and Spruce at an upsized $15 a share.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
